Pretreatment Apparent Diffusion Coefficient as a Predictor of Response to Transcatheter Arterial Chemoembolization Immediately Combined with Radiofrequency Ablation for Treatment of Solitary Large Hepatocellular Carcinoma

PURPOSE: To evaluate whether the pretreatment apparent diffusion coefficient (ADC) measured with diffusion weighted imaging (DWI) of tumor can be used as an imaging biomarker for predicting prognosis in solitary large hepatocellular carcinomas (HCCs) treated with transcatheter arterial chemoemboliza...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jing, Liu, Fengyong, Yuan, Hongjun, Li, Xin, Tian, Xiaomei, Ji, Kan, Li, Xueping, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569047/
https://www.ncbi.nlm.nih.gov/pubmed/33116868
http://dx.doi.org/10.2147/CMAR.S270470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569047/
https://www.ncbi.nlm.nih.gov/pubmed/33116868
http://dx.doi.org/10.2147/CMAR.S270470

Ejemplares similares